Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2026 and maintained its financial guidance for the
The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026,
Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro management will host a conference call and webcast
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference.
President & Chief Executive Officer, Daniel Bendheim; Chief Operating
Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial
Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2026 financial results on Wednesday, August 26, 2026, after the market closes. Phibro management will host a
The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, , payable on September 23, 2026,
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Stifel Jaws & Paws Conference.
Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America Securities Health Care Conference.
Executive Vice President, Corporate Strategy & CEO Designate Daniel
Phibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30,
The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to
Phibro Animal Health Corporation (NASDAQ:PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address
Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call and webcast on
Phibro Animal Health Corporation (NASDAQ:PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications.
The
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit.
Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller